<!DOCTYPE html>

<!--
  Created : 1/19/2012 3:54:09 PM
  Author : Tom Coleman
  Copyright : 2011-2011
  By : University of Missippi Medical Center
-->

<html>
<head>
<title> Model </title>
<link rel='stylesheet' type='text/css' href='../../Style.CSS'>
</head>

<body>

<img src='../../SmallTitle.PNG'>
<img src='../XMLLightBlue.png'>
<a href='Docs_Catechols.html'><img src='../../Back.PNG'></a>
<p>
QHP 2008 / Catechols.DOCS<br>
<br>
Created : 27-Mar-09<br>
Last Modified : 27-Mar-09<br>
Author : Tom Coleman<br>
Copyright : 2009<br>
<br>
&lt;structurename&gt; NEPool &lt;/structurename&gt;<br>
<br>
&lt;vardoc&gt;<br>
&lt;name&gt; NEPool.[NE(nMol/L)] &lt;/name&gt;<br>
&lt;topic&gt; NE - Overview &lt;/topic&gt;<br>
&lt;topic&gt; NE - Physical Units9 &lt;/topic&gt;<br>
&lt;topic&gt; NE - Concentration Units10 &lt;/topic&gt;<br>
&lt;seealso&gt; AlphaBlockade.Block(%) &lt;/seealso&gt;<br>
&lt;seealso&gt; Pheochromocytoma.Change &lt;/seealso&gt;<br>
&lt;/vardoc&gt;<br>
<br>
&lt;vardoc&gt;<br>
&lt;name&gt; NEPool.[NE(pG/mL)] &lt;/name&gt;<br>
&lt;topic&gt; NE - Overview &lt;/topic&gt;<br>
&lt;topic&gt; NE - Physical Units9 &lt;/topic&gt;<br>
&lt;topic&gt; NE - Concentration Units10 &lt;/topic&gt;<br>
&lt;/vardoc&gt;<br>
<br>
&lt;vardoc&gt;<br>
&lt;name&gt; NEPool.[NE]&lt;/name&gt;<br>
&lt;topic&gt; NE - Overview &lt;/topic&gt;<br>
&lt;topic&gt; NE - Physical Units9 &lt;/topic&gt;<br>
&lt;topic&gt; NE - Concentration Units10 &lt;/topic&gt;<br>
&lt;seealso&gt; NEPool.Mass &lt;/seealso&gt;<br>
&lt;seealso&gt; ECFV.Vol &lt;/seealso&gt;<br>
&lt;/vardoc&gt;<br>
<br>
&lt;vardoc&gt;<br>
&lt;name&gt;  NEPool.Change &lt;/name&gt;<br>
&lt;topic&gt; Change - NEPDefinition1 &lt;/topic&gt;<br>
&lt;topic&gt; NE - Physical Units9 &lt;/topic&gt;<br>
&lt;topic&gt; NE - Concentration Units10 &lt;/topic&gt;<br>
&lt;seealso&gt; NEPool.Gain &lt;/seealso&gt;<br>
&lt;seealso&gt; NEPool.Loss &lt;/seealso&gt;<br>
&lt;/vardoc&gt;<br>
<br>
&lt;vardoc&gt;<br>
&lt;name&gt; NEPool.F1 &lt;/name&gt;<br>
&lt;topic&gt; F1 - NEPDefinition2 &lt;/topic&gt;<br>
&lt;topic&gt; NE - Physical Units9 &lt;/topic&gt;<br>
&lt;topic&gt; NE - Concentration Units10 &lt;/topic&gt;<br>
&lt;/vardoc&gt;<br>
<br>
&lt;vardoc&gt;<br>
&lt;name&gt; NEPool.F2 &lt;/name&gt;<br>
&lt;topic&gt; F2 - NEPDefinition3  &lt;/topic&gt;<br>
&lt;topic&gt; NE - Physical Units9 &lt;/topic&gt;<br>
&lt;topic&gt; NE - Concentration Units10 &lt;/topic&gt;<br>
&lt;/vardoc&gt;<br>
<br>
&lt;vardoc&gt;<br>
&lt;name&gt; NEPool.Gain &lt;/name&gt;<br>
&lt;topic&gt; Gain - NEPDefinition4 &lt;/topic&gt;<br>
&lt;seealso&gt; NESecretion.Rate &lt;/seealso&gt;<br>
&lt;seealso&gt; NESecretion.Spillover &lt;/seealso&gt;<br>
&lt;seealso&gt; NEpump.Rate &lt;/seealso&gt;<br>
&lt;seealso&gt; Pheochromocytoma.NERate &lt;/seealso&gt;<br>
&lt;/vardoc&gt;<br>
<br>
&lt;vardoc&gt;<br>
&lt;name&gt; NEPool.InitialMass &lt;/name&gt;<br>
&lt;topic&gt; InitialMass - NEPDefinition6 &lt;/topic&gt;<br>
&lt;topic&gt; NE - Physical Units &lt;/topic&gt;<br>
&lt;topic&gt; NE - Concentration Units &lt;/topic&gt;<br>
&lt;/vardoc&gt;<br>
<br>
&lt;vardoc&gt;<br>
&lt;name&gt; NEPool.Loss &lt;/name&gt;<br>
&lt;topic&gt; Loss - NEPDefinition5 &lt;/topic&gt;<br>
&lt;seealso&gt; NEClearance.Rate &lt;/seealso&gt;<br>
&lt;/vardoc&gt;<br>
<br>
&lt;vardoc&gt;<br>
&lt;name&gt; NEPool.Mass &lt;/name&gt;<br>
&lt;topic&gt; Mass - NEPDefinition7 &lt;/topic&gt;<br>
&lt;topic&gt; NE - Overview &lt;/topic&gt;<br>
&lt;topic&gt; NE - Physical Units &lt;/topic&gt;<br>
&lt;topic&gt; NE - Concentration Units &lt;/topic&gt;<br>
&lt;seealso&gt; ECFV.Vol &lt;/seealso&gt;<br>
&lt;/vardoc&gt;<br>
<br>
&lt;vardoc&gt;<br>
&lt;name&gt; NEPool.Target[NE] &lt;/name&gt;<br>
&lt;topic&gt; Target[NE] - NEPDefinition8 &lt;/topic&gt;<br>
&lt;/vardoc&gt;<br>
<br>
&lt;topicdoc&gt;<br>
&lt;name&gt; NE - Overview &lt;/name&gt;<br>
&lt;label&gt; Overview &lt;/label&gt;<br>
&lt;content&gt;<br>
<br>
Norepinephrine (NE) is the neurotransmitter released <br>
from axon terminals of sympathetic postganglionic neurons. <br>
Norepinephrine is also released from the adrenal medullae <br>
in response to sympathetic nerve stimulation. <br>
Under resting conditions, only a few percent of the NE <br>
entering the plasma represents adrenal medullary secretion. <br>
The remainder has its source in the neurotransmitter released <br>
by sympathetic nerve varicosities. This NE is referred to <br>
as spillover. Total body spillover can be measured using a <br>
tracer kinetic method based on dilution of [3H]NE by endogenous NE.<br>
<br>
Esler M, Jennings G, Lambert G, Meredith I, Horne M, Eisenhofer G.<br>
Overflow of catecholeamine neurotransmitters to the circulation:<br>
Source, fate and Functions. Physiol Rev 70:963-985, 1990<br>
<br>
Goldstein DS, Eisenhofer G, Kopin IJ. Sources and significance<br>
of plasma levels of catechols and their metabolites in humans.<br>
J Pharmacol Exp Ther 305(3): 800-811, 2003.<br>
<br>
NE excites both alpha and beta adrenergic receptors and causes<br>
a range of different effects in different effector organs <br>
depending on the plasma concentration and the density and types <br>
of receptors present. In patients with pheochromocytoma, an <br>
increase in plasma NE causes symptoms which include <br>
hypertension, severe headaches, palpitations and excess sweating. <br>
These symptoms reflect the effects of norepinephrine <br>
on alpha and beta adrenergic receptors respectively.<br>
<br>
&lt;/content&gt;<br>
&lt;/topicdoc&gt;<br>
<br>
&lt;topicdoc&gt;<br>
&lt;name&gt; NE - Physical Units9 &lt;/name&gt;<br>
&lt;label&gt; Physical Units &lt;/label&gt;<br>
&lt;content&gt;<br>
<br>
[Plasma]    pG/mL or nMol/L  <br>
pG/mL * 0.00592 = nMol/L<br>
nMol * 0.1692 = ug<br>
Mass nG or pG<br>
<br>
milli = 10^-3<br>
micro = 10^-6<br>
nano  = 10^-9<br>
pico  = 10^-12<br>
<br>
<br>
&lt;/content&gt;<br>
&lt;/topicdoc&gt;<br>
<br>
&lt;topicdoc&gt;<br>
&lt;name&gt; NE - Concentration Units10 &lt;/name&gt;<br>
&lt;label&gt; Concentration Units &lt;/label&gt;<br>
&lt;content&gt;<br>
<br>
Norepinephrine (C8 H11 N O3) has a molecular<br>
weight of 169. Typical plasma concentration of <br>
NE is 240pG/mL or 1.42nMol/L (Multiply by 0.00592<br>
to convert pG/mL to nMol/L)<br>
<br>
The NE Pool or mass is a function of NE Secretion, <br>
NE Clearance and the volume of distribution. <br>
Since the volume of distribution for epinephrine is <br>
the ECFV (15,000 mL), the typical circulating pool<br>
is 3600 nG<br>
<br>
&lt;/content&gt;<br>
&lt;/topicdoc&gt;<br>
<br>
&lt;topicdoc&gt;<br>
&lt;name&gt; Change - NEPDefinition1 &lt;/name&gt;<br>
&lt;label&gt; Definition &lt;/label&gt;<br>
&lt;content&gt;<br>
<br>
Changes in the NE pool or mass are a function of both<br>
gains and losses in NE over time. Gains may occur from<br>
increased secretion due to sympathetic nerve stimulation;<br>
from infusion of NE using the NE pump feature of the<br>
model and/or increases from a NE secreting pheochromocytoma.<br>
<br>
&lt;/content&gt;<br>
&lt;/topicdoc&gt; <br>
<br>
&lt;topicdoc&gt;<br>
&lt;name&gt; F1 - NEPDefinition2 &lt;/name&gt;<br>
&lt;label&gt; Definition &lt;/label&gt;<br>
&lt;content&gt;<br>
<br>
F1 is a mathematical variable used in the calculation of<br>
the mass or pool of NE. F1 is the gain in NE over time and<br>
is a function of NE secretion rate, NE spillover rate, NE <br>
pump rate and pheochromocytoma NE rate<br>
<br>
&lt;/content&gt;<br>
&lt;/topicdoc&gt;<br>
<br>
<br>
&lt;topicdoc&gt;<br>
&lt;name&gt; F2 - NEPDefinition3 &lt;/name&gt;<br>
&lt;label&gt; Definition &lt;/label&gt;<br>
&lt;content&gt;<br>
<br>
F2 is a mathematical variable used in the calculation of <br>
the mass of NE. F2 is the loss in NE over time and is<br>
a function of NE clearance rate. <br>
<br>
&lt;/content&gt;<br>
&lt;/topicdoc&gt;<br>
<br>
&lt;topicdoc&gt;<br>
&lt;name&gt; Gain - NEPDefinition4 &lt;/name&gt;<br>
&lt;label&gt; Definition &lt;/label&gt;<br>
&lt;content&gt;<br>
<br>
Gain is defined as positive changes in mass of NE <br>
and is a function of NE secretion rate, NE spillover,<br>
NE from infusion (using the NE pump feature) and<br>
any NE secretion from a possible pheochromocytoma.<br>
The model user may create a pheochromocytoma and <br>
define different levels of severity.<br>
<br>
&lt;/content&gt;<br>
&lt;/topicdoc&gt;<br>
<br>
&lt;topicdoc&gt;<br>
&lt;name&gt; Loss - NEPDefinition5 &lt;/name&gt;<br>
&lt;label&gt; Definition &lt;/label&gt;<br>
&lt;content&gt;<br>
<br>
Loss is defined as a negative change in mass of NE<br>
and is a function of clearance rate.<br>
<br>
&lt;/content&gt;<br>
&lt;/topicdoc&gt;<br>
<br>
&lt;topicdoc&gt;<br>
&lt;name&gt; InitialMass - NEPDefinition6 &lt;/name&gt;<br>
&lt;label&gt; Definition &lt;/label&gt;<br>
&lt;content&gt;<br>
<br>
The initial mass is the starting amount of NE.<br>
Since the plasma concentration of NE (the target[NE])is <br>
240pG/mL and the volume of distribution for epinephrine is <br>
the ECFV (15,000 mL), the typical initial mass<br>
is 3600 nG (0.24*15,000).<br>
<br>
Initial Mass = Target[NE]*ECFV.Vol<br>
<br>
&lt;/content&gt;<br>
&lt;/topicdoc&gt; <br>
<br>
&lt;topicdoc&gt;<br>
&lt;name&gt; Mass - NEPDefinition7 &lt;/name&gt;<br>
&lt;label&gt; Definition &lt;/label&gt;<br>
&lt;content&gt;<br>
<br>
Mass or pool is the calculated amount of circulating<br>
NE. Gains and losses in NE are integrated over time<br>
to calculate the NE Pool or mass.<br>
<br>
&lt;/content&gt;<br>
&lt;/topicdoc&gt;  <br>
<br>
&lt;topicdoc&gt;<br>
&lt;name&gt; Target[NE] - NEPDefinition8 &lt;/name&gt;<br>
&lt;label&gt; Definition &lt;/label&gt;<br>
&lt;content&gt;<br>
<br>
During startup, the model user defines the particular <br>
traits of the HumMod patient. These are gender, body size, <br>
age, muscularity and adiposity. All of these traits <br>
influence body volumes, most notably the extracellular <br>
fluid volume (ECFV). The assumption is made that<br>
while volumes may change with traits, concentrations do <br>
not. At startup,initial volumes,especially ECFV and plasma <br>
volume are calculated. A target concentration is specified <br>
- in this case Target[NE]. <br>
<br>
The initial mass or circulating pool is the Target[NE] <br>
multiplied by the initial volume of distribution, in <br>
this case the ECFV.<br>
 <br>
Initial Mass = Target[NE]*ECFV.InitialVol(L)<br>
<br>
The Target[NE] is the starting plasma concentration of<br>
norepinephrine. Under normal physiological<br>
conditions Target[NE] is 240pG/mL<br>
<br>
&lt;/content&gt;<br>
&lt;/topicdoc&gt; <br>
  <br>
End

<p><img src='../../Footer.PNG'>

</body>
</html>
